1
Home
Companies

SINTX Technologies

#10241

Rank

$12.66M

Marketcap

US United States

Country

SINTX Technologies
Leadership team

Dr. B. Sonny Bal J.D., M.B.A., M.D., MBA, Ph.D. (Chairman, Pres, CEO & Principal Financial Officer)

Mr. David Francis O'Brien (Chief Operating Officer)

Ms. Gina Moss (Director of Operations)

Products/ Services
Biotechnology, Health Care, Medical Device
Headquarters
Salt Lake City, Utah, United States
Established
1996
Company Registration
SEC CIK number: 0001269026
Revenue
500K - 2M
Traded as
SINT
Social Media
URL
https://www.sintx.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
History

SINTX Technologies was founded in 2001. The company has developed a proprietary nano-crystalline material offering superior mechanical, electrical, and thermal stability compared to various metal and metalized ceramics. SINTX has expanded its production capabilities and resources, entering into numerous business partnerships and affiliations with prominent medical device companies.

Mission
SINTX Technologies is committed to providing advanced biomedical and nanotechnology solutions that improve medical treatments and lives.
Vision
SINTX Technologies strives to become a global leader in developing and manufacturing nanotechnology-based medical devices.
Key Team

Dr. B. Sonny Bal J.D., M.B.A., M.D., MBA, Ph.D. (Chairman, Pres, CEO & Principal Financial Officer)

Mr. David Francis O'Brien (Chief Operating Officer)

Ms. Gina Moss (Director of Operations)

Recognition and Awards
SINTX Technologies has received numerous awards, including the R&D 100 Award, the Development of Spinal Technology Award, and the Global Innovation Award.
References

https://in.investing.com/equities/amedica-cor

https://finance.yahoo.com/quote/SINT/profile?p=SINT

https://www.crunchbase.com/organization/amedica

https://companiesmarketcap.com/

https://www.sintx.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

SINTX Technologies
Leadership team

Dr. B. Sonny Bal J.D., M.B.A., M.D., MBA, Ph.D. (Chairman, Pres, CEO & Principal Financial Officer)

Mr. David Francis O'Brien (Chief Operating Officer)

Ms. Gina Moss (Director of Operations)

Products/ Services
Biotechnology, Health Care, Medical Device
Headquarters
Salt Lake City, Utah, United States
Established
1996
Company Registration
SEC CIK number: 0001269026
Revenue
500K - 2M
Traded as
SINT
Social Media
URL
https://www.sintx.com